Dave Barrett


Dave Barrett partners with emerging companies focused on cloud infrastructure, data science-fueled SaaS applications and healthcare technologies. He joined Polaris in 2000 after 17 years as an operating executive and entrepreneur.

Dave serves on the boards of EgnyteInsideSales.comNotarizeOM1Recurly, SimonData and Sonrai Security. He also works closely with Lob and Voysis.

Previously, he closely partnered with and served on the boards of many transformative companies from inception through scaling, including: Archivas (Hitachi Data Systems), Automattic/WordPress, Bitium (Google), Confluence (TA Associates), CliQr (Cisco), Imprivata (NASDAQ: IMPR, Thoma Bravo), Logentries (Rapid7), LogMeIn (NASDAQ: LOGM), MarkMonitor (Thomson Reuters), Phytel (IBM), Q1 Labs (IBM) and vKernel (Dell).

He divides his time across San Francisco, Boston and New York City.

Prior to joining Polaris, Dave was operating officer of Calico, a pioneering e-commerce infrastructure provider. During his leadership, the company evolved from startup through public operations with $50 million in revenues and $3.5 billion in market value. Before that, he was senior vice president of worldwide operations for Pure Atria/Rational Software Corporation, a publicly-held market leader in software development automation with more than $150 million in revenues. Rational was acquired by IBM for over $2 billion. Earlier, in 12 years with Lotus Development Corporation/IBM in a number of executive roles including vice president & general manager of sales and services, he helped build Lotus to become one of the two largest software companies in the world before it was acquired by IBM for $3.5 billion.

Dave is an Always-On Venture Capital 100 and Venture Capital East 50 recipient and has been named both an Always-On “Cloud Power Player” and “FinTech Power Player”. He’s been a mentor for TechStars, Harvard iLab and IBM SmartCamp, a guest lecturer at Harvard, HBS, and a founding member of the Microsoft Advisory Board.  He also serves on the Board of the Dana-Farber Cancer Institute, as well as on their investment committee.

He received a B.S. from The University of Rhode Island.